Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.1800
+0.0150 (9.09%)
Sep 15, 2025, 4:20 PM AEST

ASX:LDX Revenue

In the fiscal year ending June 30, 2025, Lumos Diagnostics Holdings had annual revenue of $12.40M USD with 11.40% growth. Lumos Diagnostics Holdings had revenue of $6.09M in the half year ending June 30, 2025, with 11.86% growth.

Revenue
$12.40M
Revenue Growth
+11.40%
P/S Ratio
7.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
139.62M AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202512.40M1.27M11.40%
Jun 30, 202411.13M596.00K5.66%
Jun 30, 202310.54M-1.10M-9.42%
Jun 30, 202211.63M-7.22M-38.32%
Jun 30, 202118.85M13.06M225.25%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Pro Medicus212.98M
Cochlear2.34B
Sonic Healthcare9.65B
Ramsay Health Care17.79B
Ansell3.06B
Telix Pharmaceuticals1.01B
Mesoblast26.23M
Revenue Rankings